Fig. 2From: Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in unresectable hepatocellular carcinoma: a systematic review and meta-analysisRisk of bias graph: with review of authors’ judgements about each risk of bias item presented as percentages across all included studiesBack to article page